Active Ingredient History
Diammonium carbonate is a salt with the chemical formula (NH4)2CO3. Since it readily degrades to gaseous ammonia and carbon dioxide upon heating, it is used as a leavening agent and also as smelling salt. Ammonium carbonate may be used as a leavening agent in traditional recipes, particularly those from northern Europe and Scandinavia (e.g. Speculoos, Tunnbröd or Lebkuchen). It also serves as an acidity regulator and has the E number E503. Ammonium carbonate is the main component of smelling salts, although the commercial scale of their production is small. Buckley's cough syrup from Canada today uses ammonium carbonate as an active ingredient intended to help relieve symptoms of bronchitis. Ammonium carbonate is also used as an emetic. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Combination drugs
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Accidental Falls (Phase 2)
Acidosis (Phase 4)
Acute Kidney Injury (Phase 4)
Anemia, Sickle Cell (Phase 1)
Anesthesia (Phase 4)
Anesthesia, General (Phase 1)
Anesthesia, Local (Phase 4)
Aortic Valve Disease (Phase 4)
Behavior (Phase 4)
Blood Pressure (Phase 4)
Body Weight (Phase 4)
Brain Edema (Early Phase 1)
Cardiopulmonary Bypass (Phase 2/Phase 3)
Cathartics (Phase 4)
Catheterization, Central Venous (Phase 2)
Catheter-Related Infections (Phase 4)
Catheters (Phase 4)
Cells (Phase 4)
Cesarean Section (Phase 3)
Colonoscopy (Phase 4)
Colorectal Neoplasms (Phase 2)
Contrast Media (Phase 4)
Coronary Artery Disease (Phase 4)
Coronary Disease (Phase 4)
Coronavirus (Phase 4)
Coronavirus Infections (Phase 4)
COVID-19 (Phase 4)
Critical Care (Phase 4)
Cystic Fibrosis (Phase 1)
Cystitis, Interstitial (Phase 2)
Death, Sudden, Cardiac (Phase 4)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 1 (Phase 4)
Diabetic Nephropathies (Phase 4)
Dialysis (Phase 4)
Diarrhea (Phase 1/Phase 2)
Drugs, Investigational (Phase 4)
Esophagitis (Phase 4)
Extravasation of Diagnostic and Therapeutic Materials (Phase 2/Phase 3)
Fatigue (Phase 2)
Filtration (Phase 2/Phase 3)
Fractures, Bone (Phase 2)
Gastric Acid (Phase 3)
General Surgery (Phase 4)
Gout (Phase 2)
Hamartoma (Phase 4)
Headache (Phase 2/Phase 3)
Head and Neck Neoplasms (Phase 2)
Healthy Volunteers (Phase 4)
Heart Arrest (Phase 4)
Heartburn (Phase 4)
Heart Defects, Congenital (Phase 2)
Heart Diseases (Phase 2)
Helicobacter Infections (Phase 3)
Hematologic Diseases (Phase 2)
Hematologic Neoplasms (Phase 1)
Hemodialysis, Home (Phase 4)
HIV (Phase 1)
Human Experimentation (Phase 3)
Hypertension (Phase 1)
Hypokalemia (Phase 4)
Hypotension (Phase 4)
Insulin Resistance (Phase 2)
Intestinal Failure (Phase 2)
Intestine, Large (Phase 3)
Kidney Calculi (Phase 4)
Kidney Diseases (Phase 4)
Kidney Failure, Chronic (Phase 4)
Kidney Transplantation (Phase 4)
Leukemia, Myeloid, Acute (Early Phase 1)
Live Birth (Phase 3)
Lung Neoplasms (Phase 4)
Lymphoma (Phase 1)
Membranes (Phase 4)
Mitochondrial Diseases (Phase 2)
Mucositis (Phase 4)
Multiple Myeloma (Phase 1)
Muscle Hypotonia (Phase 2)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 3)
Nephrolithiasis (Phase 4)
Obstetric Labor Complications (Phase 3)
Oliguria (Phase 2)
Oral Hygiene (Phase 4)
Oropharyngeal Neoplasms (Phase 3)
Osteoarthritis (Phase 2/Phase 3)
Osteoporosis (Phase 2)
Pain ()
Pancreatic Neoplasms (Phase 1)
Pelvic Pain (Phase 3)
Performance-Enhancing Substances (Early Phase 1)
Pharmacokinetics (Phase 1)
Physical Endurance (Phase 2)
Pneumonia (Early Phase 1)
Poisoning (Phase 4)
Polycystic Kidney, Autosomal Dominant (Phase 2)
Pregnancy Complications (Phase 3)
Prostatic Neoplasms (Early Phase 1)
Pulmonary Embolism (Phase 4)
Pulmonary Ventilation (Early Phase 1)
Pulpitis (Phase 4)
Renal Artery Obstruction (Phase 4)
Renal Dialysis (Phase 1)
Renal Insufficiency (Phase 4)
Renal Insufficiency, Chronic (Phase 4)
Renal Replacement Therapy (Phase 2)
Rhytidoplasty (Phase 3)
Safety (Phase 4)
Saline Solution, Hypertonic (Early Phase 1)
Sarcoma (Phase 2)
Shock (Phase 3)
Shock, Septic (Phase 4)
Sports (Phase 3)
Stomach Diseases (Phase 3)
Stomach Neoplasms (Early Phase 1)
Stomach Ulcer (Phase 1)
Stomatitis (Phase 4)
Surgical Wound Infection (Phase 2/Phase 3)
Systemic Inflammatory Response Syndrome (Phase 2)
Thoracic Surgery (Phase 2/Phase 3)
Urinary Bladder Diseases (Phase 2)
Urinary Bladder, Overactive (Phase 4)
Urinary Incontinence, Stress (Phase 2)
Urinary Incontinence, Urge (Phase 4)
Varicose Veins (Phase 4)
Vascular Access Devices (Phase 4)
Vascular Diseases (Phase 4)
Venous Cutdown (Phase 2/Phase 3)
Venous Thromboembolism (Phase 2/Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue